Epigenetic Variations in Prostate Tumors May Determine Choice Between Definitive Treatment and Active Surveillance
October 16th 2013
Prostate cancer is the most common cancer and second leading cause of cancer mortality in American men. Nevertheless, it is estimated that only 3% of the patients will die because of their cancer, while the majority will die of competing causes.